Form 4 for NXL Nexalin Technology, Inc.
Accepted 2024-06-12 00:00:00 ET · period of report 2024-06-10 · accession 0001829126-24-004108 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-06-12 | 2024-06-10 | NXL | Owens David | Chief Medical Off, Dir | P - Purchase | $0.64 | +3,000 | 144.2K | +2% | +$1,920 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-06-10 | P | A | 2,000 | $0.65 | 143,174 | D | — | — | |
| 2 | Common | Common stock | 2024-06-10 | P | A | 1,000 | $0.62 | 144,174 | D | — | — |